CN101686955A - 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 - Google Patents

用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 Download PDF

Info

Publication number
CN101686955A
CN101686955A CN200880018706A CN200880018706A CN101686955A CN 101686955 A CN101686955 A CN 101686955A CN 200880018706 A CN200880018706 A CN 200880018706A CN 200880018706 A CN200880018706 A CN 200880018706A CN 101686955 A CN101686955 A CN 101686955A
Authority
CN
China
Prior art keywords
desmethylvenlafaxine
sleep
duloxetine
administered
odv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880018706A
Other languages
English (en)
Chinese (zh)
Inventor
迪安·A·汉德利
拉里·W·哈代
梅达德·瓦里茨·帕瑟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of CN101686955A publication Critical patent/CN101686955A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200880018706A 2007-04-09 2008-04-08 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 Pending CN101686955A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
US60/922,466 2007-04-09
PCT/US2008/004508 WO2008124128A2 (en) 2007-04-09 2008-04-08 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders

Publications (1)

Publication Number Publication Date
CN101686955A true CN101686955A (zh) 2010-03-31

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880018706A Pending CN101686955A (zh) 2007-04-09 2008-04-08 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物

Country Status (15)

Country Link
US (3) US20080293823A1 (https=)
EP (2) EP2455076A1 (https=)
JP (1) JP2010523662A (https=)
KR (1) KR20100015923A (https=)
CN (1) CN101686955A (https=)
AR (1) AR065989A1 (https=)
AU (1) AU2008236624A1 (https=)
BR (1) BRPI0810159A2 (https=)
CA (1) CA2683697C (https=)
IL (1) IL201430A0 (https=)
MX (1) MX2009010805A (https=)
NZ (1) NZ580250A (https=)
RU (1) RU2009141168A (https=)
TW (1) TW200901956A (https=)
WO (1) WO2008124128A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012007813A (es) * 2010-01-07 2012-08-01 Vivus Inc Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
EP3746126B1 (en) 2018-01-30 2024-07-31 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea or simple snoring
EP4635514A3 (en) * 2019-02-08 2025-12-24 The Brigham & Women's Hospital, Inc. Methods and compositions for treating sleep apnea

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US6110973A (en) 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
DE60039132D1 (de) * 1999-04-06 2008-07-17 Sepracor Inc O-Desmethylvenlafaxin-Succinat
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
NZ548856A (en) * 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039867A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders with setiptiline
KR20070087678A (ko) * 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
AU2006255047B2 (en) * 2005-06-06 2011-09-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating sleep disorders
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
KR101528326B1 (ko) * 2007-02-21 2015-06-11 선오비온 파마슈티컬스 인코포레이티드 （―）ｏ―데스메틸벤라팍신을 포함하는 고체 형태들 및 그들의 용도
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

Also Published As

Publication number Publication date
MX2009010805A (es) 2009-10-29
JP2010523662A (ja) 2010-07-15
TW200901956A (en) 2009-01-16
BRPI0810159A2 (pt) 2014-12-30
EP2142183A2 (en) 2010-01-13
US20150196531A1 (en) 2015-07-16
KR20100015923A (ko) 2010-02-12
AU2008236624A1 (en) 2008-10-16
AR065989A1 (es) 2009-07-15
IL201430A0 (en) 2010-05-31
US20080293823A1 (en) 2008-11-27
RU2009141168A (ru) 2011-05-20
US20120238616A1 (en) 2012-09-20
WO2008124128A3 (en) 2009-05-07
NZ580250A (en) 2012-05-25
EP2455076A1 (en) 2012-05-23
WO2008124128A2 (en) 2008-10-16
CA2683697A1 (en) 2008-10-16
CA2683697C (en) 2016-08-16

Similar Documents

Publication Publication Date Title
US20210401777A1 (en) Methods and compositions for treating sleep apnea
JP7422666B2 (ja) 睡眠時無呼吸を治療するための方法および組成物
TW200524582A (en) Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US20250114321A1 (en) Methods and compositions for treating sleep apnea
TW200803901A (en) Methods of treating anxiety disorders
CN101686955A (zh) 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物
PT92799B (pt) Utilizacao de um agonista parcial de glicina b, nomeadamente um composto amino-isoxazolidina, para a preparacao de um medicamento empregue como antipsicotico e processo para a preparacao de uma composicao farmaceutica contendo o referido agonista
US20240277719A1 (en) Norepinephrine reuptake inhibitors for treating sleep apnea
CN117062626A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
WO2021202906A1 (en) Methods and compositions for treating sleep apnea
HK1142005A (en) Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
HK40120547A (zh) 用於治疗睡眠呼吸暂停的方法和组合物
KR20250057804A (ko) 수면 무호흡증을 치료하기 위한 방법 및 조성물
EP4301353A1 (en) Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea
CN117615764A (zh) 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂
US20090239909A1 (en) Treatment of metabolic syndrome with lactams
US20080182898A1 (en) Treatment of metabolic syndrome with norfluoxetine
HK40013951A (en) Methods and compositions for treating sleep apnea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1142005

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100331

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1142005

Country of ref document: HK